Lv21
174 积分 2022-09-08 加入
Arterial Administration of DNA Crosslinking Agents with Restraint of Homologous Recombination Repair by Intravenous Low-Dose Gemcitabine Is Effective for Locally Advanced Pancreatic Cancer
4天前
已完结
Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA Repair
4天前
已完结
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer
4天前
已完结
Selective targeting of homologous DNA recombination repair by gemcitabine
4天前
已完结
Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine
4天前
已完结
Depatuxizumab mafodotin in glioblastoma: A systematic review of efficacy, safety, pharmacokinetics and biomarker stratification
12天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
12天前
已完结
SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial
12天前
已完结
Integrative Oncology for Prostate Cancer: A Narrative Review
14天前
已完结
A Comparison of Methods for Treatment Selection in Seamless Phase II/III Design
14天前
已完结
皖公网安备34019202002308
